The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Research & Development: BDT Mil (TTM As of . 20)


DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
20 GF Score
Price BDT318.20
View Full Analysis

What is The IBN SINA Pharmaceutical Industry Research & Development?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA +0.47% 20 Research & Development is BDT Mil as of . 20. GuruFocus rates DHA:IBNSINA with a GF Score™ of 20/100.

Research & Development is the aggregate amount of research and development expenses during the year. The IBN SINA Pharmaceutical Industry's Research & Development for the six months ended in . 20 was BDT0.00 Mil. The IBN SINA Pharmaceutical Industry does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

The IBN SINA Pharmaceutical Industry  (DHA:IBNSINA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

The IBN SINA Pharmaceutical Industry Research & Development Related Terms

The IBN SINA Pharmaceutical Industry Research & Development Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry Research & Development Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
Research & Development

The IBN SINA Pharmaceutical Industry Semi-Annual Data
Research & Development
DHA:IBNSINA
20GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of BDT Mil mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a Research & Development of BDT Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on The IBN SINA Pharmaceutical Industry and its competitors.
Is The IBN SINA Pharmaceutical Industry's Research & Development too high?
The IBN SINA Pharmaceutical Industry's current Research & Development is BDT Mil. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's Research & Development compare to IMNPQ?
The IBN SINA Pharmaceutical Industry's Research & Development of BDT Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. The IBN SINA Pharmaceutical Industry's current Research & Development is BDT Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current Research & Development of BDT Mil. The current Research & Development is BDT Mil. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current Research & Development is BDT Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
20GF Score

Get the complete analysis for DHA:IBNSINA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT318.20
Price